Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Pharmacotherapy of obsessive-compulsive disorder in a health maintenance organization
Autore:
Koran, LM; Leventhal, JL; Fireman, B; Jacobson, A;
Indirizzi:
Stanford Univ, Med Ctr, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA Stanford Univ Stanford CA USA 94305 t & Behav Sci, Stanford, CA 94305 USA Kaiser Permanente No Calif, Div Res, Oakland, CA USA Kaiser Permanente No Calif Oakland CA USA alif, Div Res, Oakland, CA USA Kaiser Permanente No Calif, Med Care Program, Oakland, CA USA Kaiser Permanente No Calif Oakland CA USA Care Program, Oakland, CA USA
Titolo Testata:
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
fascicolo: 21, volume: 57, anno: 2000,
pagine: 1972 - 1978
SICI:
1079-2082(20001101)57:21<1972:POODIA>2.0.ZU;2-D
Fonte:
ISI
Lingua:
ENG
Soggetto:
PRIMARY-CARE; DEPRESSED-PATIENTS; CLOMIPRAMINE; MEDICATIONS; MANAGEMENT; DISCONTINUATION; UNDERTREATMENT; INTERVENTIONS; OUTPATIENTS; GUIDELINES;
Keywords:
adolescents; antidepressants; compliance; dosage; dosage schedules; health maintenance organizations; obsessive-compulsive disorder; pediatrics; phenelzine; prescribing; psychotherapeutic agents; rational therapy;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Life Sciences
Citazioni:
35
Recensione:
Indirizzi per estratti:
Indirizzo: Koran, LM Stanford Univ, Med Ctr, Dept Psychiat & Behav Sci, Room 2363,401Quarry Rd, Stanford, CA 94305 USA Stanford Univ Room 2363,401 Quarry Rd Stanford CA USA 94305 USA
Citazione:
L.M. Koran et al., "Pharmacotherapy of obsessive-compulsive disorder in a health maintenance organization", AM J HEAL S, 57(21), 2000, pp. 1972-1978

Abstract

The adequacy of pharmacotherapy for patients with obsessive-compulsive disorder (OCD) in a large, prepaid HMO was studied. An analysis was made of the computerized records for December 1, 1994 through April 30, 1998 for members of a Kaiser Permanent plan in northern California who were six years of age or older and had had continuous membership during an index year (May 1, 1995, to April 30 1996) (1.728 million members). A total of 880 adults and 168 children and adolescents with chart-review-confirmed OCD and a pharmacy benefit were identified. The percentage of patients with an adequate drug trial, defined as greater than or equal to 56 days of continuous treatment with a serotonin-reuptake inhibitor or phenelzine at dosages at or above established minimal effective dosages, was determined. Forty-three percent of the adults and 28% of the children and adolescents who were newly diagnosed with OCD in the index year had an adequate trial of medication in the year after their first visit for OCD. By the second sixmonths after the index year, only 75.2% of newly treated adults and 60.9% of newly treated children and adolescents continuing in the health plan filled at least one anti-OCD prescription. During the second follow-up year, these figures fell to 60.4% and 38.9%, respectively. Continuing-care patients filling a prescription in the index year were more likely than newly diagnosed patients to fill prescriptions in the two year follow-up period, but their treatment still decreased substantially. Despite the typically chronic course of OCD, many patients with OCD who were enrolled in a large HMO appeared not to receive an adequate trial of pharmacotherapy or ongoing pharmacotherapy.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 22/01/20 alle ore 21:49:37